Multiplexed single-cell transcriptional response profiling to define cancer vulnerabilities and therapeutic mechanism

James M McFarland1, Brenton R Paolella1, Allison Warren1

  • 1Broad Institute of MIT and Harvard, Cambridge, 021242, MA, USA.

Nature Communications
|August 29, 2020
PubMed

Insights

This study introduces MIX-Seq, a novel method for analyzing cancer cell responses across many cell lines simultaneously. MIX-Seq uses single-cell RNA sequencing to reveal detailed gene expression changes, aiding drug discovery and treatment prediction.

Area of Science:

  • Genomics
  • Molecular Biology
  • Cancer Research

Background:

  • Traditional cancer cell response assays rely on limited phenotypic readouts like proliferation.
  • Information-rich methods like gene-expression profiling are inefficient for multi-context perturbation studies.

Purpose of the Study:

  • To develop MIX-Seq, a method for multiplexed transcriptional profiling of post-perturbation cancer cell responses.
  • To enable single-cell resolution analysis across a mixture of samples for comprehensive perturbation studies.

Main Methods:

  • MIX-Seq utilizes SNP-based computational demultiplexing of single-cell RNA sequencing (scRNA-seq) data.
  • The method allows profiling responses across pooled cancer cell lines (100+).
  • Cell Hashing is combined with MIX-Seq to multiplex additional experimental variables like time points or drug doses.

Main Results:

  • MIX-Seq successfully profiled responses to chemical and genetic perturbations in large pools of cancer cell lines.
  • Analysis of high-content scRNA-seq data revealed shared and context-specific transcriptional response patterns.
  • These patterns identified drug mechanisms of action and predicted long-term cell viability from short-term responses.

Conclusions:

  • MIX-Seq offers an efficient approach for high-content transcriptional profiling of cancer cell responses.
  • The method facilitates the discovery of drug mechanisms and prediction of treatment outcomes.
  • This advancement supports personalized medicine by enabling detailed analysis of drug effects in diverse cellular contexts.